论文部分内容阅读
自体造血干细胞移植治疗恶性淋巴瘤的近况达万明近代化、放疗的进展虽可使约６０％的何杰金淋巴瘤（ＨＤ）和近３０％的非ＨＤ（ＮＨＬ）长期存活，但对复发或持续未达缓解（ＣＲ）的病例，特别对中、高恶组ＮＨＬ的长期生存改善不明显；实验证明，化、放疗的效果与其剂量...
Progress in the treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation Although the progress of modernization and radiotherapy of Da Wanming can make about 60% of Hodgkin’s lymphoma (HD) and nearly 30% of non-HD (NHL) survive for a long period of time, Or the case of sustained remission (CR), especially for the long-term survival of the middle and high-negative group NHL is not obvious; experiments have shown that the effect of chemotherapy and radiotherapy and its dose ...